Last CNY29.97 CNY
Change Today -0.81 / -2.63%
Volume 15.3M
600332 On Other Exchanges
600332 is not on other exchanges.
As of 2:05 AM 01/29/15 All times are local (Market data is delayed by at least 15 minutes).

guangzhou baiyunshan phar-a (600332) Snapshot

Previous Close
Day High
Day Low
52 Week High
01/19/15 - CNY33.21
52 Week Low
04/28/14 - CNY22.23
Market Cap
Average Volume 10 Days
Shares Outstanding
Dividend Yield
Current Stock Chart for GUANGZHOU BAIYUNSHAN PHAR-A (600332)

Related News

No related news articles were found.

guangzhou baiyunshan phar-a (600332) Related Businessweek News

No Related Businessweek News Found

guangzhou baiyunshan phar-a (600332) Details

Guangzhou Baiyunshan Pharmaceutical Holdings Company Limited is engaged in the research, development, manufacture, and sale of Chinese patent medicines (CPM) and health products primarily in the People’s Republic of China. It is also involved in the production and sale of prepackaging food, dairy products, etc; sale of Chinese herbal medicines; wholesale and retail of western pharmaceutical products, medical apparatus, CPM, and Chinese raw medicines; and wholesale of goods other than pharmaceutical products. As of December 31, 2013, the company had 36 retail chain pharmacy outlets, including 35 outlets under the Cai Zhi Lin name and 1 pharmacy under the Ying Bang name. It also exports its products. The company was formerly known as Guangzhou Pharmaceutical Company Limited and changed its name to Guangzhou Baiyunshan Pharmaceutical Holdings Company Limited in August 2013. The company was founded in 1997 and is headquartered in Guangzhou, the People’s Republic of China. Guangzhou Baiyunshan Pharmaceutical Holdings Company Limited is a subsidiary of Guangzhou Pharmaceutical Holdings Limited.

11,284 Employees
Last Reported Date: 03/17/14
Founded in 1997

guangzhou baiyunshan phar-a (600332) Top Compensated Officers

General Manager, Executive Director and Membe...
Total Annual Compensation: CNY1.1M
Chairman and Chairman of Strategic Developmen...
Total Annual Compensation: --
Executive Director and Member of Budget Commi...
Total Annual Compensation: --
Total Annual Compensation: CNY709.0K
Compensation as of Fiscal Year 2013.

guangzhou baiyunshan phar-a (600332) Key Developments

Guangzhou Pharmaceutical Signs Cooperation Agreement with Alibaba Health Information Tech

Guangzhou Pharmaceutical Co. Ltd. announced on late that it had signed an agreement with Alibaba Health Information Technology Limited, on cooperation of medical E-commerce supplier, medical health services, and big health industry.

Guangzhou Plans To Sell Its Stake To Jack Ma

Guangzhou Baiyunshan Pharmaceutical Holdings Company Limited (SEHK:874) is planning to sell CNY 10 billion stake to a consortium that includes a private equity group Co-Founded by Alibaba Chairman Jack Ma. The stock rose 18.8% in Hong Kong to close at HKD 27.85 and rose by the intraday limit of 10% in Hong Kong.

Guangzhou Baiyunshan Pharmaceutical Holdings Company Limited Proposes Amendments to the Articles of Association

Guangzhou Baiyunshan Pharmaceutical Holdings Company Limited proposed amendments to the articles of association. The proposed amendments to the articles of association are subject to the Shareholders approval at the EGM. The company proposed new provisions for Article 6,9,18,51,55,65,66, Clause (1) of Article 73, Article 217,81,88,89,82,91,93,97.


Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup
Recently Viewed
600332:CH CNY29.97 CNY -0.81

600332 Competitors

Market data is delayed at least 15 minutes.

Company Last Change
No competitor information is available for 600332.
View Industry Companies

Industry Analysis


Industry Average

Valuation 600332 Industry Range
Price/Earnings 34.8x
Price/Sales 2.0x
Price/Book 5.2x
Price/Cash Flow 28.5x
TEV/Sales 1.4x

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact GUANGZHOU BAIYUNSHAN PHAR-A, please visit Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at